25.09.2022 | Breast Oncology
Screening MRI in Patients with High-Risk Breast Lesions: More May Not Necessarily be More
verfasst von:
Juan C. Paramo, MD, Roshni Rao, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 1/2023
Einloggen, um Zugang zu erhalten
Excerpt
The ability to image breast tissue is fortuitously multimodal. Mammographic screening has been proven to decrease breast cancer mortality,
1 and although there remains controversy over optimal frequency and age of initiation, this modality is universally endorsed as an effective tool for identifying cancers at an earlier stage.
2 Whereas magnetic resonance imaging (MRI) of the breast has the highest cancer detection rate of all breast imaging modalities,
3 the rate of false positives and potentially unnecessary biopsies precludes its use as a widespread screening tool. Surveillance with MRI is therefore indicated primarily for patients who are at such elevated breast cancer risk that the risk of false-positive biopsies is outweighed by the benefits of potential early detection.
4 …